hVIVO (LSE:HVO) Accounts Payable : £2.09 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is hVIVO Accounts Payable?

hVIVO's Accounts Payable for the quarter that ended in Dec. 2023 was £2.09 Mil.

hVIVO's quarterly Accounts Payable declined from Dec. 2022 (£2.70 Mil) to Jun. 2023 (£1.32 Mil) but then increased from Jun. 2023 (£1.32 Mil) to Dec. 2023 (£2.09 Mil).

hVIVO's annual Accounts Payable increased from Dec. 2021 (£2.06 Mil) to Dec. 2022 (£2.70 Mil) but then declined from Dec. 2022 (£2.70 Mil) to Dec. 2023 (£2.09 Mil).

hVIVO Accounts Payable Historical Data

The historical data trend for hVIVO's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Accounts Payable Chart

hVIVO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.51

2.27

2.06

2.70

2.09

hVIVO Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															2.06	23.73	2.70	1.32	2.09

hVIVO Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

hVIVO Accounts Payable Related Terms

Thank you for viewing the detailed overview of hVIVO's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO (LSE:HVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

OPORF:USA HVO:Ireland ORPH:UK CRO:Germany

Address

42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.hvivo.com

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO (LSE:HVO) Headlines

No Headlines